Evidence-Based Recommendations on the Use of Immunotherapies and Monoclonal Antibodies in the Treatment of Male Reproductive Cancers.

In another study, also randomized and placebo-controlled, indicated a possible improvement in survival rates for those patients who are treated with sipuleucel-T, though the results did not reach statistical significance.

also in 111,027 other papers